Wolfgang Linz
25Patents
9h-index
46Co-inventors
71Inventor score
Filing activity: Oct 17, 1989 → Jun 14, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6602866B2 | Mercaptoacetylamide derivatives, a process for their preparation and their use | Human Necessities | 123 | Expired |
| US5091394A | Benzoylguanidines, a process for their preparation, their use as medicaments and medicaments containing them | Chemistry; Metallurgy | 45 | Expired |
| US5292755A | USPA benzolyguanidines | Chemistry; Metallurgy | 34 | Expired |
| US5236943A | Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia | Human Necessities | 22 | Expired |
| US5231083A | Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia | Human Necessities | 21 | Expired |
| US5364868A | Amino-substituted benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them | Chemistry; Metallurgy | 20 | Expired |
| US5574069A | Substituted benzenesulfonylureas and -thioureas- process for their preparation and their use as pharmaceuticals | Chemistry; Metallurgy | 13 | Expired |
| US6420430B1 | Use of inhibitors of the sodium-hydrogen exchanger for preparing a medicament for preventing age-related disorders, and for prolonging life | Human Necessities | 13 | Expired |
| US5849755A | 3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them | Chemistry; Metallurgy | 10 | Expired |
| US5698596A | Substituted benzenesulfonylureas and thioureas process for their preparation and their use as pharmaceuticals | Chemistry; Metallurgy | 8 | Expired |
| US5468764A | Angiotensin II receptor antagonists for the treatment of disturbances in cardiac rhythm | Human Necessities | 7 | Expired |
| US6335467B1 | Substituted benzenesulfonylureas and thioureas-process for their preparation and their use as pharmaceuticals | Chemistry; Metallurgy | 6 | Expired |
| US5482957A | Azole derivatives, process for their preparation and their use | Chemistry; Metallurgy | 6 | Expired |
| US6462024B1 | Use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substrates of the heart | Human Necessities | 6 | Expired |
| US5025010A | Benzothiazinone derivatives, and pharmaceuticals containing them | Human Necessities | 4 | Expired |
| US6090981A | Substituted benzenesulfonylureas and -thioureas--process for their preparation and their use as pharmaceuticals | Chemistry; Metallurgy | 4 | Expired |
| US5776980A | Substituted benzenesulfonylureas and -thioureas-process for their preparation and their use as pharmaceuticals | Chemistry; Metallurgy | 3 | Expired |
| US5811448A | Substituted chromanysulfonyl (thio) ureas, processing for their preparation and pharmaceutical uses thereof | Chemistry; Metallurgy | 3 | Expired |
| US5374731A | Amino acid derivatives with renin-inhibiting properties, a process for the preparation thereof, agents containing these, and the use thereof | Chemistry; Metallurgy | 1 | Expired |
| US6844361B2 | Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor | Human Necessities | 1 | Expired |
| US7601863B2 | Use of PPAR agonists for the treatment of congestive heart failure | Human Necessities | 0 | Active |
| US7514423B2 | Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases | Human Necessities | 0 | Active |
| US8088799B2 | Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor | Human Necessities | 0 | Active |
| US6930103B2 | Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases | Human Necessities | 0 | Expired |
| US6506937B2 | Substituted benzenesulfonylureas and -thioureas-processes for their preparation and their use as pharmaceuticals | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.